Michael A. Robinson
On Tuesday, we talked about a “Trump-proof” way to play China’s exploding social media and e-commerce markets.
I told you I would follow up soon with another tech-based “frontier” investment.
Today I’m keeping that promise.
With 1.3 billion residents, India is the globe’s second-most-populous nation. And it could surpass China in as little as five years.
India logged GDP growth of 7% in last year’s fourth quarter. That beat forecasts by 10%. Even if that were to slow by as much as 20%, India’s economy would still be expanding twice as fast as that of the United States.
In just the past decade, India’s $2.2 trillion economy has leaped past Italy, Brazil, Canada, South Korea, and Russia. That means it’s now the globe’s seventh-largest economy – and it could move up to fifth place by 2020.
Hot China Stocks For 2018: XOMA Corporation(XOMA)
Advisors’ Opinion:
- [By Lisa Levin]
Shares of XOMA Corporation (NASDAQ: XOMA) got a boost, shooting up 31 percent to $14.69. Wedbush upgraded XOMA from Neutral to Outperform.
Energous Corp (NASDAQ: WATT) shares were also up, gaining 17 percent to $11.89. Energous reported a new, high-power, Near Field WattUp charging solution for electronic devices.
- [By Spencer Israel]
The following are some of the stocks discussed on the show for which co-host Joel Elconin offered technical levels.
Bank of America Corp (NYSE: BAC) hit a low last week of $22.43, and has a big psychological level of $22.
Goldman Sachs Group Inc (NYSE: GS) has two minor support levels from early December of $221.22 and $220.35. Under $220 it gets dicey, with support at $214.97 and $209.92.
United States Steel Corporation (NYSE: X) has a key low of $31.33 from February 2. That number serves as support.
Best Buy Co Inc (NYSE: BBY) has a triple top at $45.15. It's currently in a trading range from $43.75-$45.70.
Shake Shack Inc (NYSE: SHAK) has been range bound over the last four days from $31.68 to $32.62. It has major support at the all-time low from March 15 at $30.36.
Warren Lorenz, CEO of TechMeetsTrader, joined the show to discuss his "Facebook for stocks" platform, and how he learned how to trade by watching trading communities. Listen to the full interview with Lorenz here.
Tommy Lackey, managing partner and portfolio manager at Relativity Capital Advisors, told us which stocks are on his nitrous scans and meltdown filters this morning. Those include XOMA Corporation (NASDAQ: XOMA) Whirlpool Corporation (NYSE: WHR) and Bed Bath & Beyond Inc. (NASDAQ: BBBY). Listen to the full interview with Lackey here.
With the market in a slight selloff following Friday's healthcare fallout, the focus today will be which sectors, if any, rebound throughout the day. With steel stocks looking weak and gold minors and utilities looking strong, co-host Dennis Dick said he'll try to jump into those sectors if they stay weak after the open. Hear what other sectors Dick is watching here.
With Snap Inc (NYSE: SNAP)'s 25-day quiet period for analysts over, the Street was treated to bullish ratings by Goldman Sachs, Citigroup, Morgan Stanley and others. It's worth noting, however, most of Monday morning
Hot China Stocks For 2018: Medtronic plc(MDT)
Advisors’ Opinion:
- [By Ben Levisohn]
US sequential acceleration returns to the prior curve and debunks the bear case. Sequential growth in US [transcatheter aortic valve replacement, or TAVR,] in 1Q17 was ~12%, more in line with the ~13.5% average growth rate seen in the five quarters leading up to 3Q16. It’s hard to pinpoint the drivers, but we see several dynamics, including: (i) underlying device utilization thus far in 1Q, (ii) faster ramp at new hospitals where one additional TAVR per center is worth $15mn (~65% of the US upside we saw this quarter), and (iii) less acute competitive pressure from Medtronic (MDT) on larger valve sizes. SURTAVI likely played a limited role but management did not rule it out. Guidance implies a more conservative q/q US growth of ~3% for the rest of the year vs the ~12% this quarter, but underlying strength in the quarter is a material shift in US growth and intermediate penetration. As we stated in our preview, we favored the risk reward into the quarter given achievable expectations and the >20 point lag vs Intuitive YTD and would expect significant recovery tomorrow. Momentum likely continues into 2Q17 as signs of improving intermediate risk penetration provide important offsets to increased competition from Boston in early-2018 before mitral takes hold.
- [By James E. Brumley]
When an investor thinks of stocks in the cardio-monitoring arena, names like General Electric Company (NYSE:GE) and Medtronic PLC (NYSE:MDT) tend to surface first. And well they should. Medtronic is the largest name dedicated solely to equipment that tells doctors and nurses how well a patient’s heart is functioning, while GE Healthcare smartly leverages the name of its parent company’s recognizable name to win market share in the medical equipment space.
General Electric and Medtronic aren’t the only names in town, however, and certainly not the top prospects for an investor seeking out a fresh, undiscovered growth opportunity. That honor arguably belongs to an up-and-coming small cap outfit called Biotricity Inc. (OTCMKTS:BTCY), which is nearing its first-ever revenue.
Don’t look for a Biotricity product quite yet, as they’re not on the market. Consumers as well as investors will want to keep their eyes and ears open for two of them soon though, however, with one of those devices being a high-precision, FDA-approved instrument for use by healthcare workers in a clinical setting. The other device is a consumer-oriented version of the same technology, giving BTCY access to not just one but two crucial markets. Even more recently Biotricity reported it was opening up its development pipeline to the fetal monitoring and sleep apnea markets. Heart-monitoring is the near-term venture, though.
The two products are called biotricity and biolife (neither moniker is supposed to be capitalized). The latter is a wireless, remote consumer-oriented heart rate and activity monitoring device, and the former is a clinical-grade monitoring device… also wireless and remotely operated/monitored.
Bioflux is only available by prescription. The bioflux hardware includes an ECG (heart-rhythm) monitoring device, software, and if desired, service from a monitoring lab that performs remote diagnostic monitoring for up to 30 consecutive days at a time. It
- [By Nelson Hem]
Lawrence C. Strauss’s “Medtronic: Healthy and Getting Healthier” points out that some investors are skeptical about the prospects for this Dublin-based medical device maker. But are those investors underestimating the strength of Medtronic PLC (NYSE: MDT)? Find out why Barron’s believes the company’s shares could climb up to 15 percent over the next 12 months.
Hot China Stocks For 2018: Neometals Ltd (RRSSF)
Advisors’ Opinion:
- [By SEEKINGALPHA.COM]
The other producing lithium miners, and soon to be producers. I have discussed these previously in detail here, here and here. Needless to say, the top 3 producers are non-pure plays (SQM (NYSE:SQM), Albemarle (NYSE:ALB), and FMC Corp. (NYSE:FMC)). The top pure play currently producing miners are Orocobre (ASX:ORE) (OTCPK:OROCF), Tianqi Lithium (SHE:002466), Jiangxi Ganfeng Lithium, Galaxy Resources, Mineral Resources [ASX:MIN] (OTC:MALRF), and Neometals [ASX:NMT] (OTC:RRSSF). The near-term producers include Altura Mining [ASX:AJM] (OTCPK:ALTAF), Pilbara Minerals (ASX:PLS) (OTC:PILBF), Kidman Resources (ASX:KDR), Critical Elements, Nemaska Lithium (OTCQX:NMKEF) [TSX:NMX], Lithium Americas (OTCQX:LACDF) [TSX:LAC], Lithium X (OTCQX:LIXXF) (TSXV:LIX), Neo Lithium, and Bacanora Minerals (OTC:BCRMF) [TSXV:BCN], Advantage Lithium (OTCQB:AVLIF) [AAL], European Metals (OTCPK:MNTCF, ASX:EMH, AIM:EMH) and Pure Energy (OTCQB:PEMIF) [PE].
